Saumu Ahmed
Bagamoyo, United Republic of Tanzania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial.
Journal: The Lancet. Infectious diseases
Published: September 30, 2025
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Journal: The Lancet. Infectious diseases
Published: March 25, 2024
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Journal: Med (New York, N.Y.)
Published: April 14, 2023
Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers: An Open-Label, Single-Arm, Dose-Escalation Study on Maytenus senegalensis in Tanzania.
Journal: Tropical medicine and infectious disease
Published: October 24, 2022
Motivations and barriers for healthy participants to participate in herbal remedy clinical trial in Tanzania: A qualitative study based on the theory of planned behaviour.
Journal: PloS one
Published: January 28, 2022
Posttreatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum Malaria.
Journal: The Journal of infectious diseases
Published: July 27, 2017
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
Journal: The New England journal of medicine
Published: November 10, 2012
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
Journal: The New England journal of medicine
Published: October 20, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026